Related Experiment Video
Updated: Apr 7, 2026
06:38
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
1.8K
Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea
1Diagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan, Kansas, USA wpzhang@vet.k-state.edu.
Clinical and Vaccine Immunology : CVI
|July 3, 2015
Summary
New subunit vaccines targeting enterotoxigenic Escherichia coli (ETEC) show promise for preventing childhood diarrhea. These polypeptide vaccines induce antibodies against key virulence factors, offering broad protection against ETEC infections.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Enterotoxigenic Escherichia coli (ETEC) is a primary cause of infectious diarrhea and mortality in young children globally.
- Existing whole-cell vaccine candidates for ETEC lack efficacy and can cause adverse effects.
- There are currently no licensed vaccines available to prevent ETEC-associated diarrhea.
Purpose of the Study:
- To evaluate the potential of polypeptide or subunit vaccines against ETEC diarrhea.
- To assess the immunogenicity and efficacy of novel ETEC antigen constructs.
Main Methods:
- Development of multiepitope fusion antigens (MEFA) combining ETEC colonization factor antigens (CFAs) and toxoids of heat-labile (LT) and heat-stable (STa) toxins.
- Immunization studies to assess the induction of antiadhesin and antitoxin antibodies.
- Evaluation of antibody cross-reactivity against multiple CFAs and neutralization of ETEC toxins.
Main Results:
- CFA-based antigens induced cross-reactive antibodies inhibiting adherence of major ETEC CFAs.
- Fusion toxoids neutralized both LT and STa enterotoxins.
- Combined CFA-toxoid MEFA polypeptides generated broad antiadhesin and antitoxin antibody responses, targeting ~80% of ETEC strains with known CFAs and all ETEC toxin types.
Conclusions:
- Polypeptide or subunit vaccines represent a promising strategy for preventing ETEC diarrhea.
- Novel adhesins and mucin proteases may serve as additional antigens for future ETEC vaccine development.
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
8.1K
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10.5K
Related Concept Videos
01:18Bacterial Gastroenteritis
48
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
48
01:21Vaccines
51
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
51
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
550
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
550
01:25Cholera
72
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
72
01:17Drugs for Treatment of Diarrhea-Predominant IBS
903
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
903
01:12Bacterial Toxins
57
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
57